Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Biological and Environmental Research
Grant: P30GM133894
National Institute of Allergy and Infectious Diseases
Grant: R21 AI127249
National Institute of Allergy and Infectious Diseases
Grant: 1P01AI138212
National Institute of Allergy and Infectious Diseases
Grant: R01 AI081625
National Institute of Allergy and Infectious Diseases
Grant: R01 AI122912
U.S. Department of Energy
Grant: DE-AC02-05CH11231
U.S. Department of Energy
Grant: DE-AC02-76SF00515
NIAID NIH HHS
Grant: P01 AI138212
NIH HHS
Grant: S10 OD021832
National Institutes of Health
Grant: 3P30GM133894-06S1
A Synchrotron Radiation Structural Biology Resource
National Institutes of Health
Grant: 5R01AI122912-03
Identification and Analysis of HIV-specific Naive B cells in HIV-unexposed Individuals
National Institutes of Health
Grant: 1R21AI127249-01
Germline-targeting anti-idiotype antibodies as novel HIV-1 immunogens
National Institutes of Health
Grant: 7R01AI081625-06
Monitoring the development of anti-Env Abs during HIV infection
National Institutes of Health
Grant: 1P01AI138212-01A1
Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs
NIH
FWCI
2.03
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals